Intravenous Administration Is an Effective and Safe Route for Cancer Gene Therapy Using the Bifidobacterium-Mediated Recombinant HSV-1 Thymidine Kinase and Ganciclovir. [electronic resource]
Producer: 20170406ISSN:- 1422-0067
- Administration, Intravenous
- Animals
- Apoptosis -- drug effects
- Bifidobacterium -- physiology
- Biomarkers
- Caspase 8 -- metabolism
- Cell Line, Tumor
- Cytokines -- genetics
- Disease Models, Animal
- Ganciclovir -- administration & dosage
- Gene Expression
- Genetic Therapy -- methods
- Genetic Vectors -- administration & dosage
- Herpesvirus 1, Human -- genetics
- Humans
- Male
- Mice
- Neoplasms -- genetics
- Signal Transduction -- drug effects
- Thymidine Kinase -- genetics
- Toll-Like Receptor 2 -- genetics
- Tumor Burden -- drug effects
- Xenograft Model Antitumor Assays
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.